Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 249124, 5 pages
http://dx.doi.org/10.5402/2012/249124
Clinical Study

High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

1Bone Marrow and Stem Cell Transplantation Program, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman 11941, Jordan
2Department of Internal Medicine, King Hussein Cancer Center, Amman 11941, Jordan

Received 27 August 2011; Accepted 18 October 2011

Academic Editors: M. Emoto and T. S. Ganesan

Copyright © 2012 Fawzi Abdel-Rahman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fawzi Abdel-Rahman, Ayad Hussein, Mohammad Aljamily, Abdulhadi Al-Zaben, Nilly Hussein, and Ala'a Addasi, “High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables,” ISRN Oncology, vol. 2012, Article ID 249124, 5 pages, 2012. doi:10.5402/2012/249124